Las Vegas, NV., Feb. 01, 2018 -- StereoVision Entertainment Inc (OTC:SVSN) a publicly traded company announced today that the “America 1st VA Hospital Tour” hits the Miami VA Hospital Auditorium this Valentine's Day, featuring the Dixie Dolls Trio.
“This Miami VA Hospital Auditorium event is a big show for our ”America 1st VA Hospital Tour,” said CannaVision’s Chairman Dr. Jay Ellenby M.D. “Among some of the other performers joining the Dixie Dolls Trio this Valentine's Day will be the Miami Heat Cheerleaders and the Miami Dolphin’s Cheerleaders. We’ve very proud and fully committed to advocating for veterans use of medical marijuana. In a documentary we working on, interviewing homeless vets we’ve found considerable anecdotal evidence that medical marijuana is the only effective substitute for opiods, and after they stop being given the opioids, heroin. Please write or call your Senator or Congressman and demand Vets be given the choice!”
StereoVision Entertainment http://stereovision.com Headquartered in Las Vegas, Nevada StereoVision is a publicly traded Nevada corporation (OTC:SVSN) focused on creating, acquiring, and producing multimedia content with its media subsidiaries, the wholly owned 9 time Emmy Award winning production company REZN8, http://rezn8.com, the majority owned family entertainment company, Inspirational Vision Media, http://ivmi.biz, and the majority owned Florida medical marijuana clinic and organic/industrial hemp corporation MediCannaVision Inc., dba CannaVision. http://cannavisionclinics.com
Safe Harbor Statement: Except for historical information certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and those statements are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The Company cautions that these forward-looking statements are qualified by other factors. The Company undertakes no obligation to publicly update any statements in this release, whether as a result of future events, or otherwise.
Contact: StereoVision Entertainment Steven Previch 305-972-2018 [email protected]


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Washington Post Publisher Will Lewis Steps Down After Layoffs
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Anta Sports Expands Global Footprint With Strategic Puma Stake
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 



